Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 42

1.

Concordance of genotype for polymorphisms in DNA isolated from peripheral blood and colorectal cancer tumor samples.

van Huis-Tanja L, Kweekel D, Gelderblom H, Koopman M, Punt K, Guchelaar HJ, van der Straaten T.

Pharmacogenomics. 2013 Dec;14(16):2005-12. doi: 10.2217/pgs.13.169.

PMID:
24279855
2.

CDKN2A (INK4A-ARF) mutation analysis to distinguish cutaneous melanoma metastasis from a second primary melanoma.

Blokx WA, Lesterhuis WJ, Andriessen MP, Verdijk MA, Punt CJ, Ligtenberg MJ.

Am J Surg Pathol. 2007 Apr;31(4):637-41. Erratum in: Am J Surg Pathol. 2007 Jul;31(7):1137. Lesterhuis, Joost J [corrected to Lesterhuis, W Joost]; Punt, Kees J A [corrected to Punt, Cornelis J A].

PMID:
17414113
3.

Attenuation of simian immunodeficiency virus SIVmac239 infection by prophylactic immunization with dna and recombinant adenoviral vaccine vectors expressing Gag.

Casimiro DR, Wang F, Schleif WA, Liang X, Zhang ZQ, Tobery TW, Davies ME, McDermott AB, O'Connor DH, Fridman A, Bagchi A, Tussey LG, Bett AJ, Finnefrock AC, Fu TM, Tang A, Wilson KA, Chen M, Perry HC, Heidecker GJ, Freed DC, Carella A, Punt KS, Sykes KJ, Huang L, Ausensi VI, Bachinsky M, Sadasivan-Nair U, Watkins DI, Emini EA, Shiver JW.

J Virol. 2005 Dec;79(24):15547-55.

4.

Standardization of cytokine flow cytometry assays.

Maecker HT, Rinfret A, D'Souza P, Darden J, Roig E, Landry C, Hayes P, Birungi J, Anzala O, Garcia M, Harari A, Frank I, Baydo R, Baker M, Holbrook J, Ottinger J, Lamoreaux L, Epling CL, Sinclair E, Suni MA, Punt K, Calarota S, El-Bahi S, Alter G, Maila H, Kuta E, Cox J, Gray C, Altfeld M, Nougarede N, Boyer J, Tussey L, Tobery T, Bredt B, Roederer M, Koup R, Maino VC, Weinhold K, Pantaleo G, Gilmour J, Horton H, Sekaly RP.

BMC Immunol. 2005 Jun 24;6:13.

5.

Intracellular staining for HIV-specific IFN-gamma production: statistical analyses establish reproducibility and criteria for distinguishing positive responses.

Trigona WL, Clair JH, Persaud N, Punt K, Bachinsky M, Sadasivan-Nair U, Dubey S, Tussey L, Fu TM, Shiver J.

J Interferon Cytokine Res. 2003 Jul;23(7):369-77.

PMID:
14511463
6.

Factors related to high levels of ostrich chick mortality from hatching to 90 days of age in an intensive rearing system.

Cloete SW, Lambrechts H, Punt K, Brand Z.

J S Afr Vet Assoc. 2001 Dec;72(4):197-202.

PMID:
12219914
7.

Replication-incompetent adenoviral vaccine vector elicits effective anti-immunodeficiency-virus immunity.

Shiver JW, Fu TM, Chen L, Casimiro DR, Davies ME, Evans RK, Zhang ZQ, Simon AJ, Trigona WL, Dubey SA, Huang L, Harris VA, Long RS, Liang X, Handt L, Schleif WA, Zhu L, Freed DC, Persaud NV, Guan L, Punt KS, Tang A, Chen M, Wilson KA, Collins KB, Heidecker GJ, Fernandez VR, Perry HC, Joyce JG, Grimm KM, Cook JC, Keller PM, Kresock DS, Mach H, Troutman RD, Isopi LA, Williams DM, Xu Z, Bohannon KE, Volkin DB, Montefiori DC, Miura A, Krivulka GR, Lifton MA, Kuroda MJ, Schmitz JE, Letvin NL, Caulfield MJ, Bett AJ, Youil R, Kaslow DC, Emini EA.

Nature. 2002 Jan 17;415(6869):331-5.

PMID:
11797011
8.

Mean cardiac output by thermodilution with a single controlled injection.

Jansen JR, Schreuder JJ, Punt KD, van den Berg PC, Alfieri O.

Crit Care Med. 2001 Oct;29(10):1868-73.

PMID:
11588442
9.

Control of viremia and prevention of clinical AIDS in rhesus monkeys by cytokine-augmented DNA vaccination.

Barouch DH, Santra S, Schmitz JE, Kuroda MJ, Fu TM, Wagner W, Bilska M, Craiu A, Zheng XX, Krivulka GR, Beaudry K, Lifton MA, Nickerson CE, Trigona WL, Punt K, Freed DC, Guan L, Dubey S, Casimiro D, Simon A, Davies ME, Chastain M, Strom TB, Gelman RS, Montefiori DC, Lewis MG, Emini EA, Shiver JW, Letvin NL.

Science. 2000 Oct 20;290(5491):486-92.

10.

Cardiotoxicity as a dose-limiting factor in a schedule of high dose bolus therapy with interleukin-2 and alpha-interferon. An unexpectedly frequent complication.

Kruit WH, Punt KJ, Goey SH, de Mulder PH, van Hoogenhuyze DC, Henzen-Logmans SC, Stoter G.

Cancer. 1994 Nov 15;74(10):2850-6.

PMID:
7954247
11.

Repetitive weekly cycles of 4-day continuous infusion of recombinant interleukin-2: a phase I study.

Punt KC, Jansen RL, De Mulder PH, Batchelor D, Galazka A, Bolhuis RL, Stoter G.

J Immunother (1991). 1992 Nov;12(4):277-84.

PMID:
1477079
12.

The use of amsacrine plus intermediate-dose cytosine arabinoside in relapsed and refractory acute nonlymphocytic leukemia.

Dekker AW, Punt K, Verdonck LF.

Haematol Blood Transfus. 1987;30:333-5. No abstract available.

PMID:
3623240
13.

Depletion of T cells from bone marrow grafts with soybean agglutinin and sheep red blood cells for prevention of graft-versus-host disease.

Verdonck LF, Dekker AW, van Heugten H, van Kempen ML, Punt K, de Gast GC.

Haematol Blood Transfus. 1987;30:563-6. No abstract available.

PMID:
3305219
14.

[Increased susceptibility for infection in malignant diseases of the lymphatic system].

de Gast GC, Punt K.

Ned Tijdschr Geneeskd. 1986 Sep 13;130(37):1633-5. Dutch. No abstract available.

PMID:
3762768
15.
16.

Meningeal involvement in patients with acute nonlymphocytic leukemia. Incidence, management, and predictive factors.

Dekker AW, Elderson A, Punt K, Sixma JJ.

Cancer. 1985 Oct 15;56(8):2078-82.

PMID:
4027935
17.

Age dependent behaviour of red cell glycolytic enzymes in haematological disorders.

Jansen G, Koenderman L, Rijksen G, Punt K, Dekker AW, Staal GE.

Br J Haematol. 1985 Sep;61(1):51-9.

PMID:
4052331
18.

Intensive cytotoxic therapy followed by autologous bone marrow transplantation for non-Hodgkin's lymphoma of high-grade malignancy.

Verdonck LF, Dekker AW, van Kempen ML, Punt K, van Unnik JA, van Peperzeel HA, de Gast GC.

Blood. 1985 Apr;65(4):984-9.

19.

Non-secreting extramedullary plasmacytoma with late involvement of the pancreas causing obstructive jaundice.

Speelberg B, Kluin PM, Punt K, Lips CJ.

Neth J Med. 1985;28(7):291-94. No abstract available.

PMID:
4033832
20.

Cerebrospinal fluid concentrations of cytosine arabinoside during intravenous therapy with intermediate dose: a preliminary report.

van Prooijen HC, Punt K, Muus P.

Br J Haematol. 1985 Jan;59(1):188-90. No abstract available.

PMID:
3970851
21.

Low dose cytosine arabinoside (Ara C) in myelodysplastic syndromes.

Tricot G, De Bock R, Dekker AW, Boogaerts MA, Peetermans M, Punt K, Verwilghen RL.

Br J Haematol. 1984 Oct;58(2):231-40.

PMID:
6591945
22.
23.

The management of acute non-lymphocytic leukaemia in adults. Evaluation of the results in a non-selected group of 114 patients.

Dekker AW, Sixma JJ, Punt K.

Neth J Med. 1982;25(9):297-302. No abstract available.

PMID:
7177261
24.

Human erythrocyte pyruvate kinase deficiency: the use of a kinetic study of mutant enzymes for the detection of heterozygotes.

Sprengers ED, Marie J, Kahn A, Punt K, Staal GE.

Hum Genet. 1978 Feb 23;41(1):61-72.

PMID:
631861
25.

[A patient with splenomegaly and pancytopenia].

Punt K, Swaen GJ, Mouton RP, Sixma JJ.

Ned Tijdschr Geneeskd. 1977 Jan 22;121(4):144-8. Dutch. No abstract available.

PMID:
834337
26.

Letter: Philadelphia chromosome in acute lymphocytic leukaemia.

van Biervliet JP, van Hemel J, Geurts K, Punt K, de Boer-Van Wering E.

Lancet. 1975 Sep 27;2(7935):617. No abstract available.

PMID:
51453
27.

[Hereditary dyserythropoietic anemia, type II (HEMPAS)].

Broeckaert-van Orshoven, Helleman PW, Louwagie AC, Nijessen JG, Punt K, van Dorpe A, Verloop MC, Verwilghen RL.

Ned Tijdschr Geneeskd. 1973 Aug 25;117(34):1270-7. Dutch. No abstract available.

PMID:
4787070
28.

[A new (?) G6PD-variant with decreased activity in a Dutch family with congenital spherocytosis].

Punt K, Staal GE, Geerdink RA, Bos CC.

Ned Tijdschr Geneeskd. 1970 Dec 26;114(52):2202-3. Dutch. No abstract available.

PMID:
5531963
29.

A possible new variant of G-6-PD with decreased activity (G-6-PD-Utrecht) in a Dutch family with hereditary spherocytosis.

Staal GE, Punt K, Geerdink RA, Bos CC, Bartstra H.

Scand J Haematol. 1970;7(5):401-3. No abstract available.

PMID:
5486782
30.

Sideruria following a single dose of desferrioxamine-B as a diagnostic test in iron overload.

Ploem JE, de Wael J, Verloop MC, Punt K.

Br J Haematol. 1966 Jul;12(4):396-408. No abstract available.

PMID:
5944488
31.

Hypochromic anaemia without iron deficiency.

Verloop MC, Hellemen PW, Punt K.

Acta Med Scand Suppl. 1966;445:249-55. No abstract available.

PMID:
5219915
32.

OCCURRENCE OF HAEMOGLOBIN H AND HAEMOGLOBIN BART'S IN ALPHA-THALASSEMIA: A FAMILY WITH 2 POSSIBLE HOMOZYGOUS CASES WITH G-6-PD-DEFICIENCY.

HELLEMAN PW, PUNT K, VERLOOP MC.

Nature. 1964 Mar 7;201:1039-40. No abstract available.

PMID:
14191584
33.

[SIDEROACHRESTIC ANEMIA IN CHILDREN].

VERLOOP MC, PUNT K, HELLEMAN P, BOS EC.

Ned Tijdschr Geneeskd. 1964 Feb 29;108:434-6. Dutch. No abstract available.

PMID:
14135835
34.

Phosphatide patterns of normal, spherocytic and elliptocytic red blood cells.

de GIER, VAN DEENEN L, GEERDINK RA, PUNT K, VERLOOP MC.

Biochim Biophys Acta. 1961 Jun 24;50:383-4. No abstract available.

PMID:
13705161
35.

Thalassemia minor associated with hemoglobin-B2 heterozygosity. A family report.

HUISMAN TH, PUNT K, SCHAAD JD.

Blood. 1961 Jun;17:747-57. No abstract available.

36.

[Gluten-free diets & steatorrhea].

HULST LA, PUNT K.

Concours Med. 1959 Jan 3;81(1):15-6 passim. French. No abstract available.

PMID:
13609168
37.

The problem of interpretation of results obtained by long-term anticoagulant treatment in myocardial infarction.

JORDAN FL, PUNT K.

Acta Med Scand. 1958 Sep 25;162(2):137-42. No abstract available.

PMID:
13582611
38.

Determination of the electrophoretic mobility of haemoglobin using paper electrophoresis.

DE WAEL J, PUNT K.

Clin Chim Acta. 1957 Oct;2(5):403-6. No abstract available.

PMID:
13489876
39.

Thalassaemiahaemoglobin E-disease in two Indo-European boys.

PUNT K, VAN GOOL J.

Acta Haematol. 1957 May;17(5):305-14. No abstract available.

PMID:
13434765
40.

[A case of acute hemolytic anemia in infectious mononucleosis].

PUNT K, VERLOOP MC.

Ned Tijdschr Geneeskd. 1955 Oct 15;99(42):3128-30. Dutch. No abstract available.

PMID:
13279983
41.

Deficiency of anti-hemophilic factor in a woman, combined with a disturbance in vascular function.

VAN CREVELD S, JORDAN FL, PUNT K, VEDER HA.

Acta Med Scand. 1955 May 18;151(5):381-9. No abstract available.

PMID:
14387573
42.

Hemorrhagic disease characterized by a combination of a shortage of anti-hemophilic factor and a vascular disorder in a woman.

VAN CREVELD S, JORDAN FL, PUNT K.

Rev Belg Pathol Med Exp. 1955 Apr;24(4):310-3. No abstract available.

PMID:
13255340

Supplemental Content

Support Center